Actively Recruiting
Lifestyle Program to Improve Heart Health in Adults with Obsessive-Compulsive Disorder A Randomized Controlled Study
Led by Karolinska Institutet · Updated on 2026-05-15
108
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating a lifestyle intervention aimed at improving health habits and reducing cardiometabolic risk factors in adults with obsessive-compulsive disorder OCD. This condition is linked to higher risks of heart and metabolic diseases, partly due to unhealthy lifestyle behaviors. This trial is the first randomized controlled study to assess the effectiveness and cost-efficiency of such an intervention for people with OCD. Participants are randomly assigned to one of two groups. The first group receives a 13-week lifestyle program including one personal session to set goals, followed by 12 weekly group sessions combining education on healthy habits and physical exercise. After these sessions, they get access to a digital booster module to maintain changes. The second group receives one individual session with feedback on their health and written advice on healthy lifestyle habits based on national guidelines. During the study, participants will wear accelerometers to measure physical activity, and assessments will take place at the start, after 14 weeks, and at 12 months to track changes in activity, diet, mental health, and cardiometabolic markers. Questionnaires and physical measurements will be used to evaluate outcomes such as stress, sleep, OCD symptoms, quality of life, and various blood tests. Safety and cost-effectiveness will also be monitored throughout the trial period.
CONDITIONS
Brief Title
A Lifestyle Intervention to Reduce Cardiometabolic Risk Factors in Individuals With Obsessive-compulsive Disorder
Research Team
S
Sofia Asplund, MSc
A
Anna Holmberg, MSc
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here